2007•PrescriberOpen access

Ropinirole and pramipexole: first dopamine agonists for RLS

Author information unavailable

Abstract

Abstract Ropinirole (Adartrel) and pramipexole (Mirapexin) are two dopamine agonists recently licensed for the treatment of moderate to severe idiopathic restless legs syndrome. In our New products review Steve Chaplin presents the clinical data relating to their effi‐cacy and Dr Ray Chaudhuri comments on their place in treatment. Copyright © 2007 Wiley Interface Ltd

Open-access reader

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Pramipexole, Ropinirole, Medicine, Dopamine agonist, Dopamine, Restless legs syndrome, Rotigotine, Pharmacology